Fundz

Olon Group finalizes acquisition of GTP Bioways Group to expand its pharmaceutical offerings

Jul 03, 2024

Acquiring Company

Olon Group

Acquired Company

GTP Bioways Group

MilanToulouseBiotechnologyPharmaceuticalManufacturingBiotechnology

Description

Olon Group, a global pharmaceutical company, has completed the acquisition of GTP Bioways Group. This strategic acquisition strengthens Olon's service pipeline, creates new business opportunities, and enhances its capabilities in the development and production of innovative therapies and high-tech pharmaceutical products.

Other recent acquisitions in Pharmaceutical and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Olon Group, and when

When Olon Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Olon Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Olon Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Olon Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Olon Group

Location

Milan, Lombardy, Italy

About

Olon Group is a global pharmaceutical company that focuses on growth, consolidation, and global market expansion through internal development and strategic acquisitions. With over four decades of experience, Olon Group is committed to advancing innovative and high-tech offerings to customers in the pharmaceutical industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Olon Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Olon Group's next move

Learn about Strategic plan

Frequently asked

Who acquired GTP Bioways Group?

GTP Bioways Group was acquired by Olon Group, based in Milan. The deal was reported on July 3, 2024. Olon Group is a global pharmaceutical company that focuses on growth, consolidation, and global market expansion through internal development and strategic acquisitions. Olon Group is privately held and operates in Biotechnology.

When did Olon Group acquire GTP Bioways Group?

Olon Group's acquisition of GTP Bioways Group was reported on July 3, 2024. Olon Group, a global pharmaceutical company, has completed the acquisition of GTP Bioways Group. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does GTP Bioways Group do?

GTP Bioways Group is a French company specializing in biologics manufacturing, ADC manufacturing, nanodrug manufacturing, fill and finish, and analytical development. It is privately held, operating in Manufacturing, and is based in Toulouse.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.